121 related articles for article (PubMed ID: 17564926)
1. Choroidal neovascularization associated with West Nile virus chorioretinitis.
Seth RK; Stoessel KM; Adelman RA
Semin Ophthalmol; 2007; 22(2):81-4. PubMed ID: 17564926
[TBL] [Abstract][Full Text] [Related]
2. Clinical course of choroidal neovascular membrane in West Nile virus chorioretinitis: a case report.
Zito R; Micelli Ferrari T; Di Pilato L; Lorusso M; Ferretta A; Micelli Ferrari L; Accorinti M
J Med Case Rep; 2021 Apr; 15(1):206. PubMed ID: 33875008
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal ranibizumab for choroidal neovascularization secondary to acute multifocal posterior placoid pigment epitheliopathy.
Mavrakanas N; Mendrinos E; Tabatabay C; Pournaras CJ
Acta Ophthalmol; 2010 Mar; 88(2):e54-5. PubMed ID: 19489761
[No Abstract] [Full Text] [Related]
4. Intravitreal bevacizumab for choroidal neovascularization secondary to inflammation.
Wolf A; Thurau S; Kook D; Hoeing A; Priglinger S; Kampik A; Haritoglou C
Acta Ophthalmol; 2010 Nov; 88(7):e295-6. PubMed ID: 19860782
[No Abstract] [Full Text] [Related]
5. Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks.
Teixeira A; Moraes N; Farah ME; Bonomo PP
Acta Ophthalmol Scand; 2006 Dec; 84(6):835-6. PubMed ID: 17083556
[No Abstract] [Full Text] [Related]
6. Choroidal neovascularization secondary to Sorsby fundus dystrophy treated with systemic bevacizumab (Avastin).
Prager F; Michels S; Geitzenauer W; Schmidt-Erfurth U
Acta Ophthalmol Scand; 2007 Dec; 85(8):904-6. PubMed ID: 17433023
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome.
Ehrlich R; Ciulla TA; Maturi R; Kheradiya NS; Hrisomalos N; Shulman S; Guess MG; Coyle E; Harris A
Retina; 2009; 29(10):1418-23. PubMed ID: 19898179
[TBL] [Abstract][Full Text] [Related]
8. [Intravitreal ranibizumab for choroidal neovascularisation associated with adult-onset vitelliform dystrophy].
Prieto-Calvo E; Torrón-Fernández Blanco C; Egea-Estopiñán C; Güerri-Monclús N; Ferrer-Novella E; Ruiz-Moreno O; Pablo-Julvez LE
Arch Soc Esp Oftalmol; 2012 May; 87(5):149-52. PubMed ID: 22554558
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
Retina; 2007; 27(4):432-8. PubMed ID: 17420694
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab for inflammatory choroidal neovascularization: results from the Pan-American Collaborative Retina Study Group at 24 months.
Arevalo JF; Adan A; Berrocal MH; Espinoza JV; Maia M; Wu L; Roca JA; Quiroz-Mercado H; Ruiz-Moreno JM; Serrano MA;
Retina; 2011 Feb; 31(2):353-63. PubMed ID: 20890239
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.
Ladas ID; Kotsolis AI; Papakostas TD; Rouvas AA; Karagiannis DA; Vergados I
Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013
[TBL] [Abstract][Full Text] [Related]
12. Reactivation West Nile virus infection-related chorioretinitis.
Beardsley R; McCannel C
Semin Ophthalmol; 2012; 27(3-4):43-5. PubMed ID: 22784261
[TBL] [Abstract][Full Text] [Related]
13. Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization.
Ruiz-Moreno JM; Montero JA; Arias L; Araiz J; Gomez-Ulla F; Silva R; Piñero DP
Retina; 2010; 30(10):1609-15. PubMed ID: 20856171
[TBL] [Abstract][Full Text] [Related]
14. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA;
Retina; 2008; 28(10):1387-94. PubMed ID: 18827735
[TBL] [Abstract][Full Text] [Related]
15. Treatment of choroidal neovascularization in pathologic myopia with intravitreal bevacizumab.
Laud K; Spaide RF; Freund KB; Slakter J; Klancnik JM
Retina; 2006 Oct; 26(8):960-3. PubMed ID: 17031300
[No Abstract] [Full Text] [Related]
16. Intravitreal Ranibizumab in the treatment of choroidal neovascularisation secondary to ocular toxocariasis in a 13-year-old boy.
Lyall DA; Hutchison BM; Gaskell A; Varikkara M
Eye (Lond); 2010 Nov; 24(11):1730-1. PubMed ID: 20930857
[No Abstract] [Full Text] [Related]
17. Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis.
Makragiannis G; Vahdani K; Carreño E; Lee RWJ; Dick AD; Ross AH
Int Ophthalmol; 2018 Apr; 38(2):781-785. PubMed ID: 28361379
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.
Bom Aggio F; Eid Farah M; Melo GB
Acta Ophthalmol Scand; 2006 Oct; 84(5):713-4. PubMed ID: 16965511
[No Abstract] [Full Text] [Related]
19. Macular functional changes evaluated with MP-1 microperimetry after intravitreal bevacizumab for subfoveal myopic choroidal neovascularization: one-year results.
Scupola A; Tiberti AC; Sasso P; Savastano MC; Mastrocola A; Marangoni D; Minnella AM; Falsini B; Balestrazzi E
Retina; 2010 May; 30(5):739-47. PubMed ID: 20038860
[TBL] [Abstract][Full Text] [Related]
20. The use of intravitreal bevacizumab to treat choroidal neovascular membranes (CNVMs).
Derriman L; Marshall J; Moorman C; Downes SM
Retina; 2008 Jun; 28(6):910; author reply 910-1. PubMed ID: 18536613
[No Abstract] [Full Text] [Related]
[Next] [New Search]
